RT Journal Article
SR Electronic
T1 New horizons in multimodality molecular imaging and novel radiotracers
JF Clinical Medicine
JO Clin Med
FD Royal College of Physicians
SP 444
OP 448
DO 10.7861/clinmedicine.17-5-444
VO 17
IS 5
A1 Sally Barrington
A1 Philip Blower
A1 Gary Cook
YR 2017
UL http://www.rcpjournals.org/content/17/5/444.abstract
AB Positron emission tomography (PET)/computerised tomography is now established in clinical practice for oncologic and non-oncological applications. Improvement and development of scanner hardware has allowed faster acquisitions and wider application. PET/magnetic resonance imaging offers potential improvements in diagnostic accuracy and patient acceptability but clinical applications are still being developed. A range of new radiotracers and non-radioactive contrast agents is likely to lead to a growth in hybrid molecular imaging applications that will allow better characterisation of disease processes.